China Medicine Corporation Obtains Australian Patent for rADTZ
http://www.finanznachrichten.de/nachrichten-2008-0 [2008-7-18]
Tag : nutritional additive
GUANGZHOU, China, July 17 /Xinhua-PRNewswire/ -- China MedicineCorporation (OTC Bulletin Board: CHME; "China Medicine" or "theCompany"), a leading distributor and developer of ethical andover-the-counter drugs, traditional Chinese medicines (TCMs),nutritional and dietary supplements, medical devices, and medicalformulations in the People's Republic of China (PRC), announcedtoday that it obtained a patent from Australia Patent Office forrecombinant Aflatoxin Detoxifizyme (rADTZ). The patent is validthrough January 13, 2025.
rADTZ is an innovative product that has the potential to detoxifyaflatoxin (AFT), a potential cancer causing agent, in food andfeed. It is a compound that is a derivation ofaflatoxin-detoxifizyme (ADTZ), an extracellular enzyme. Developedby Guangzhou Co-Win Bioengineering Co., Ltd, a subsidiary of ChinaMedicine, rADTZ can be used as an additive to remove aflatoxinsfrom animal feed as well as other food products. The Companyintends to develop rADTZ for this and other applications.
"We are proud to announce that we have achieved a major milestonein being granted a patent for rADTZ in Australia," said Mr. SenshanYang, Chairman and CEO of China Medicine. "This is a majorbreakthrough for China Medicine and it opens up the opportunity toexpand our business overseas," he added. China Medicine has alreadyobtained a patent for rADTZ from the State Intellectual PropertyOffice of China in early 2004.
GUANGZHOU, China, July 17 /Xinhua-PRNewswire/ -- China MedicineCorporation (OTC Bulletin Board: CHME; "China Medicine" or "theCompany"), a leading distributor and developer of ethical andover-the-counter drugs, traditional Chinese medicines (TCMs),nutritional and dietary supplements, medical devices, and medicalformulations in the People's Republic of China (PRC), announcedtoday that it obtained a patent from Australia Patent Office forrecombinant Aflatoxin Detoxifizyme (rADTZ). The patent is validthrough January 13, 2025.
rADTZ is an innovative product that has the potential to detoxifyaflatoxin (AFT), a potential cancer causing agent, in food andfeed. It is a compound that is a derivation ofaflatoxin-detoxifizyme (ADTZ), an extracellular enzyme. Developedby Guangzhou Co-Win Bioengineering Co., Ltd, a subsidiary of ChinaMedicine, rADTZ can be used as an additive to remove aflatoxinsfrom animal feed as well as other food products. The Companyintends to develop rADTZ for this and other applications.
"We are proud to announce that we have achieved a major milestonein being granted a patent for rADTZ in Australia," said Mr. SenshanYang, Chairman and CEO of China Medicine. "This is a majorbreakthrough for China Medicine and it opens up the opportunity toexpand our business overseas," he added. China Medicine has alreadyobtained a patent for rADTZ from the State Intellectual PropertyOffice of China in early 2004.
Related News »
In Focus »
footwear exports
Last month, European footwear manufacturers proposed extending anti-dumping measures against ..
B2B Keywords:
International market Chinese Importer Wholesale trade Wholesale products World trade Wholesale distributors International trade Foreign trade Wholesale distributor Importers Import export business Sell online Help u sell Global trade How to market a product Online supplier Wholesale product
International market Chinese Importer Wholesale trade Wholesale products World trade Wholesale distributors International trade Foreign trade Wholesale distributor Importers Import export business Sell online Help u sell Global trade How to market a product Online supplier Wholesale product
Feature Products»
Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
-
-
About Us -
Links -
Privacy Policy -
Terms of Use -
Site Map -
Contact Us -
Call Center: 0086-95105561 © 2007 Tootoo.com -
